HerbMedX
Our Pipeline
Our team of dedicated scientists and researchers are constantly exploring new avenues for drug discovery and development, with a focus on addressing unmet medical needs and improving patient outcomes.
At HerbMedX, we are committed to advancing cutting-edge therapies that have the potential to revolutionize the treatment of various diseases and conditions.
We are excited about the potential of our pipeline and remain dedicated to bringing new, innovative therapies to market to improve the lives of patients worldwide.
Our team of dedicated scientists and researchers are constantly exploring new avenues for drug discovery and development, with a focus on addressing unmet medical needs and improving patient outcomes.
At HerbMedX, we are committed to advancing cutting-edge therapies that have the potential to revolutionize the treatment of various diseases and conditions.
We are excited about the potential of our pipeline and remain dedicated to bringing new, innovative therapies to market to improve the lives of patients worldwide.
HMX202001
HMX202403
HMX202202
Insilico
Pre-clinical
Safety
Clinical-trial
Market
Eczema
Psoriasis
Leishmaniasis
TYK2
inhibitor
Multi-
target
Topical
Topical
Topical
TYK2 & TRP
inhibitor
People suffer from Psoriasis in the world
125
Mn
People suffer from Eczema in North America
40+
Mn
